REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
7.95
-0.74 (-8.57%)
At close: Sep 15, 2026, 4:00 PM EDT
7.94
0.00 (-0.06%)
After-hours: Sep 15, 2026, 7:30 PM EDT
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $524.47 million as of September 15, 2026. Its market cap has increased by 12.86% in one year.
Market Cap
524.47M
Enterprise Value
669.42M
1-Year Change
12.86%
Ranking
Category
Stock Price
$7.95
ChartMarket Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $524.47M, a decrease of -30.00%. That is a compound annual growth rate of -3.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 524.47M | -28.06% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
| Sep 17, 2015 | 749.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CorMedix | 609.91M |
| Assembly Biosciences | 606.75M |
| OmniAb | 591.74M |
| Tectonic Therapeutic | 567.91M |
| Scribe Therapeutics | 563.03M |
| Contineum Therapeutics | 557.55M |
| Prime Medicine | 556.84M |
| Eupraxia Pharmaceuticals | 555.37M |